摘要
卵巢癌常用的治疗方法是手术联合化学治疗(简称“化疗”),其中铂类与紫杉醇联合应用是一线化疗方案[1]。骨髓抑制是化疗后最常见的毒副反应之一,由于化疗药物抑制了细胞的快速分裂,致使骨髓中细胞活性降低,从而出现骨髓抑制[2],临床上主要以白细胞、红细胞、血小板及血红蛋白数量减少为主要表现,其中以白细胞数量减少较为多见,常伴随不同程度的贫血、出血及继发感染。
作者
李鹤
茹丹
周艳
张旭
丁忱欢
俞超芹
张婷婷
徐莲薇
董莉
LI He;RU Dan;ZHOU Yan;ZHANG Xu;DING Chenhuan;YU Chaoqin;ZHANG Tingting;XU Lianwei;DONG Li(Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200127,China;The First Affiliated Hospital of Naval Medical University(Changhai Hospital of Shanghai),Shanghai 200433,China;Yueyang Hospital of Integrated Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China;Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China)
出处
《上海中医药杂志》
CSCD
2024年第S01期22-29,共8页
Shanghai Journal of Traditional Chinese Medicine
基金
上海市卫健委进一步加快中医药传承创新发展三年行动计划项目(ZY[2021-2023]-0209-04)
关键词
卵巢癌骨髓抑制
海派中医妇科
中西医结合
专家共识
myelosuppression in ovarian cancer
Shanghai style traditional Chinese medicine gynecology
integration of traditional Chinese and Western medicine
expert consensus